开窗分支腔内修复术后靶血管内漏的结果分析
本研究回顾2007至2017年382例接受开窗分支腔内修复(F-BEVAR)的肾旁或胸腹主动脉瘤患者,分析靶血管内漏的发生率、结局与危险因素。出院时约10%患者存在靶血管内漏,其中三分之二可自发消退,方向分支内漏更易消退;持续性内漏需再干预,动脉瘤破裂罕见。
要点
- F-BEVAR术后出院时靶血管内漏发生率约10%,多数为IIIc型。
- 方向分支内漏较开窗内漏更易发生但更易自发消退。
- 持续性内漏需再干预,再干预成功率高,破裂罕见。
核心结论
- F-BEVAR术后出院时靶血管内漏发生于约十分之一患者,其中三分之二可自发消退,尤其方向分支内漏。
- 持续性内漏经腔内再干预通常成功,动脉瘤破裂罕见。
研究设计与样本
- 回顾性队列研究,纳入2007至2017年连续接受F-BEVAR的382例患者(平均年龄75±8岁,75%男性),其中肾旁动脉瘤195例、胸腹主动脉瘤187例,共目标1204条肾-肠系膜动脉,使用981个开窗和223个方向分支。
主要发现
- 原发性内漏中25个(61%)在首次随访时自发消退(20例患者),无复发;观察的内漏中11个持续存在(9例患者),其中8个(7例患者)接受治疗;所有继发性内漏均需再干预。
- 靶血管内漏的其他危险因素包括目标血管起源处主动脉内径≥30 mm、目标血管≥4条、胸腹主动脉瘤(原发性内漏)和医生改良内移植物(继发性内漏)。
关键数值与推荐
- 原发性内漏定义为出院前CTA检出;继发性内漏定义为首次CTA未见而随访中新出现。
- 随访包括出院前、2个月、6个月及每年CTA和多普勒超声。
临床怎么用
- F-BEVAR术后应通过CTA密切监测靶血管内漏,尤其方向分支和开窗部位。
- 对于原发性靶血管内漏,可先观察,因多数(尤其方向分支)可自发消退。
- 持续性内漏需积极腔内再干预,以预防动脉瘤破裂。
局限性
- 回顾性设计,单中心经验,随访时间有限(平均24±21个月),可能影响内漏消退和再干预的评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to determine the incidence rate, outcomes, and risk factors of target vessel-related endoleaks after fenestrated-branched endovascular aortic repair (F-BEVAR) for pararenal aneurysms or thoracoabdominal aortic aneurysms (TAAAs). METHODS: We reviewed consecutive patients treated by F-BEVAR between 2007 and 2017. Target vessel endoleaks were identified by computed tomography angiography (CTA). Follow-up included CTA and duplex ultrasound before discharge, at 2 months, at 6 months, and annually thereafter. Primary endoleaks were detected by predismissal CTA; secondary endoleaks were absent on the first CTA and were identified during follow-up. End points were spontaneous resolution of primary endoleaks, secondary interventions, and aneurysm rupture. Multivariable analyses were performed for risk factors of target vessel endoleaks and predictors of spontaneous resolution. RESULTS: A total of 382 patients (mean age, 75 ± 8 years; 75% male) underwent F-BEVAR for 195 pararenal aneurysms and 187 TAAAs with 1204 renal-mesenteric arteries targeted by 981 fenestrations and 223 directional branches. Fifty-two target vessel endoleaks were identified in 41 patients; 41 were type IIIC (interattachment), 10 were type IC (distal bridging stent sealing zone), and 1 was type IIIB (bridging stent fabric tear). Thirty-three patients (9%) had primary target vessel endoleaks in 41 target vessels (3%). Eight patients (2%) developed 11 secondary target vessel endoleaks. Directional branches were more prone to primary endoleaks (13/223 [6%]) in comparison to fenestrations (28/981 [3%]; P = .03). However, branch endoleaks resolved more often spontaneously (11/14 [79%]) compared with fenestration endoleaks (14/38 [37%]; P = .008). Other risk factors for target vessel endoleaks included inner aortic diameter ≥30 mm at the target vessel origin, four or more targeted vessels, TAAA (for primary endoleaks), and physician-modified endograft (for secondary endoleaks). Four patients with primary endoleaks underwent successful reintervention before discharge, and 29 were observed with a mean follow-up of 24 ± 21 months. Of the 41 primary endoleaks, 25 resolved spontaneously in 20 patients (61%) at first follow-up with no recurrences. Of the observed endoleaks, 11 persisted in 9 patients, and 8 of those endoleaks were treated in 7 patients. All secondary target vessel endoleaks required reintervention. There was one possible aneurysm rupture attributed to persistent secondary target vessel endoleak. CONCLUSIONS: Target vessel endoleak on CTA at discharge occurs in 1 of 10 patients treated by F-BEVAR. Of these, two-thirds resolve spontaneously, especially those affecting directional branches. Among patients with a persistent endoleak, endovascular reintervention is usually successful and aneurysm rupture is rare.
引用
- Kärkkäinen JM, Tenorio ER, Jain A, et al. Outcomes of target vessel endoleaks after fenestrated-branched endovascular aortic repair. J Vasc Surg. 2020. PMID: 31980247. doi:10.1016/j.jvs.2019.09.055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。